Category: Diseases & Conditions
Diseases & Conditions market research reports by Prophecy Market Insights
-
Huntington’s Disease Treatment Market Size, Share, By Drug, Therapy Type, Route of Administration, Distribution Channel, and Region - Trends, Analysis, and Forecast till 2035
Huntington’s Disease Treatment Market Size, Share, By Drug, Therapy Type, Route of Administration, Distribution Channel, and Region - Trends, Analysis, and Forecast till 2035 Huntington’s disease (HD) is a rare hereditary neurodegenerative disorder characterized by chorea, cognitive decline, and psy ... Read More
-
Blood Cell Separation Market Size, Share, By Product (Consumables, and Instruments), Cell Type (Human Cells, Animal Cells, and Others), Technique (Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, and Filtration-based Cell Isolation), Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics, and Others), End-User (Research Laboratories and Institutes, Hospitals, and Others), and Region - Trends, Analysis and Forecast till 2035
Blood Cell Separation Market Size, Share, By Product (Consumables, and Instruments), Cell Type (Human Cells, Animal Cells, and Others), Technique (Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, and Filtration-based Cell Isolation), Application (Biomolecule Isolation, Cance ... Read More
-
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory ... Read More
-
Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic, and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chain Reaction, Next-Generation Sequencing and Others), By End User (Hospitals, Maternity And Specialty Clinics, and Diagnostic Centers), and By Region - Trends, Analysis and Forecast till 2034
Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic, and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chain Reaction, Next-Generation Sequencing and Ot ... Read More
-
Radiopharmaceutical Therapies Market Size, Share, By Radioisotope Type (Iodine-131, Gallium-68, Technetium-99m, Zirconium 89, Copper 64, Radium 223, Fluorine 18, Lutetium-177, Rubidium-82, Indium-111, and Others), By Source (Nuclear Reactors, Cyclotrons, and Others), By Application (Oncology, Cardiology, Gastroenterology, Neurology, Nephrology and Others), By End-User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) and By Region - Trends, Analysis and Forecast till 2034
In 2023, radiopharmaceuticals therapies market was estimated to be worth USD 15.32 Billion. By 2034, the target market is expected to grow to USD 27.3 Billion. Target market is expanding at a CAGR of 6.6% radiopharmaceutical therapies market involves gathering, analyzing, and interpreting informatio ... Read More
-
Anti-Obesity Medication Market Size, Share, By Drug Type, Mechanism of Action, Distribution Channel, and Region - Trends, Analysis and Forecast till 2035
Anti-obesity medication, also known as weight loss medications, are pharmacological agents that reduce or control excess body fat. Target market is driven by the increasing cases of obesity, rising awareness of the health consequences associated with being overweight. In addition, rising R&D activit ... Read More
-
PEGylated Proteins Market Size, Share, By Type (Consumables, and Services), By Protein (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, and Other), By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034
PEGylated Proteins Market Size, Share, By Type (Consumables, and Services), By Protein (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, and Other), By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Ot ... Read More
Research Assistance
